Found 138 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query: protein binding/inhibitor

Total Genus Sequence Length pdb Title
0 9 7k29P Kelch domain of human keap1 bound to nrf2 peptide, ldeetgeal
0 9 7k2aP Kelch domain of human keap1 bound to nrf2 peptide, ldeetgefa
62 283 7k29A Kelch domain of human keap1 bound to nrf2 peptide, ldeetgeal
58 282 7k2eA Kelch domain of human keap1 bound to nrf2-based cyclic peptide, c[gdeetge]
0 6 7k2nP Kelch domain of human keap1 bound to nrf2-based cyclic peptide, c[bal-deetge]
0 6 7k2pP Kelch domain of human keap1 bound to nrf2-based cyclic peptide, c[ava-dpetge]
0 7 7k2eP Kelch domain of human keap1 bound to nrf2-based cyclic peptide, c[gdeetge]
64 286 7k2bA Kelch domain of human keap1 bound to nrf2 peptide, adeetgefa
66 288 7k2hA Kelch domain of human keap1 bound to nrf2 cyclic peptide, c[gdpetge]
0 6 7k2oP Kelch domain of human keap1 bound to nrf2-based cyclic peptide, c[gaba-dpetge]
0 6 7k2sP Kelch domain of human keap1 bound to nrf2 cyclic peptide, c[dha-gdpetge]
0 7 7k2hP Kelch domain of human keap1 bound to nrf2 cyclic peptide, c[gdpetge]
58 283 7k2pA Kelch domain of human keap1 bound to nrf2-based cyclic peptide, c[ava-dpetge]
0 9 7k2bP Kelch domain of human keap1 bound to nrf2 peptide, adeetgefa
63 283 7k2aA Kelch domain of human keap1 bound to nrf2 peptide, ldeetgefa
57 283 7k2nA Kelch domain of human keap1 bound to nrf2-based cyclic peptide, c[bal-deetge]
61 283 7k2oA Kelch domain of human keap1 bound to nrf2-based cyclic peptide, c[gaba-dpetge]
0 7 7k2gP Kelch domain of human keap1 bound to nrf2 cyclic peptide, c[gdeeage]
70 288 7k2kA Kelch domain of human keap1 bound to nrf2 cyclic peptide, c[bal-deetge]
0 6 7k2kP Kelch domain of human keap1 bound to nrf2 cyclic peptide, c[bal-deetge]
59 284 7k2sA Kelch domain of human keap1 bound to nrf2 cyclic peptide, c[dha-gdpetge]
67 288 7k2gA Kelch domain of human keap1 bound to nrf2 cyclic peptide, c[gdeeage]
0 12 6opjB Menin in complex with peptide inhibitor 25
187 478 6opjA Menin in complex with peptide inhibitor 25
1 8 6keyB Structural basis for the regulation of inducible nitric oxide synthase (inos) by the spry domain-containing socs box protein 2 (spsb2)
53 200 6keyA Structural basis for the regulation of inducible nitric oxide synthase (inos) by the spry domain-containing socs box protein 2 (spsb2)
1 13 6pw8B Hydrocarbon-stapled paxillin peptide bound to the focal adhesion targeting (fat) domain of the focal adhesion kinase (fak)
57 126 6pw8A Hydrocarbon-stapled paxillin peptide bound to the focal adhesion targeting (fat) domain of the focal adhesion kinase (fak)
67 285 6v6zA Crystal structure of n-(4-((4-methoxy-n-(2,2,2-trifluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)-n-((4-methoxyphenyl)sulfonyl)glycine bound to human keap1 kelch domain
51 193 6jwnA Crystal structure of the spry domain of spsb2 in complex with cr9, a cyclic peptide inhibitor of spsb-inos interaction
56 203 6jwmA Crystal structure of the spry domain of spsb2 in complex with cr7, a potent cyclic peptide inhibitor of spsb2-inos interaction
0 7 6jwmB Crystal structure of the spry domain of spsb2 in complex with cr7, a potent cyclic peptide inhibitor of spsb2-inos interaction
0 9 6jwnB Crystal structure of the spry domain of spsb2 in complex with cr9, a cyclic peptide inhibitor of spsb-inos interaction
105 305 6pgdA Wdr5delta32 bound to peptidomimetic
104 305 6pgcA Wdr5delta32 bound to methyl benzyl(4-(4-(hydroxymethyl)-1h-imidazol-2-yl)butyl)carbamate
97 305 6pgaA Wdr5delta32 bound to methyl (4-(4-(hydroxymethyl)-1h-imidazol-2-yl)butyl)carbamate
104 305 6pgfA Wdr5delta32 bound to n-(4-(4-(hydroxymethyl)-1h-imidazol-2-yl)butyl)acrylamide
103 304 6pg9A Wdr5delta23 bound to n-(4-(5-(hydroxymethyl)-1h-imidazol-2-yl)butyl)benzamide
99 305 6pg7A Wdr5delta32 bound to (2-(3-methoxy-3-phenylpropyl)-1h-imidazol-4-yl)methanol
104 305 6pg4A Wdr5delta32 bound to (2-methyl-1h-imidazol-4-yl)methanol
102 305 6pg5A Wdr5delta32 bound to benzyl (4-(5-(hydroxymethyl)-1h-imidazol-2-yl)butyl)carbamate
102 304 6pg3A Wdr5delta23 bound to (2-butyl-1h-imidazol-4-yl)methanol
103 305 6pgbA Wdr5delta32 bound to n-(4-(5-(hydroxymethyl)-1h-imidazol-2-yl)butyl)-2-phenylacetamide
104 304 6pg8A Wdr5delta23 bound to (2-(3-phenylpropyl)-1h-imidazol-4-yl)methanol
100 305 6pgeA Wdr5delta32 bound to ethyl 3-(4-(hydroxymethyl)-1h-imidazol-2-yl)propanoate
102 304 6pg6A Wdr5delta23 bound to n-(4-(5-(hydroxymethyl)-1h-imidazol-2-yl)butyl)acetamide
38 127 6mh7A Crystal structure of the first bromodomain of human brd4 in complex with skt-68, a 1,4,5-trisubstituted imidazole analogue
0 7 5z8hB Apc with an inhibitor
55 233 6albA Crebbp bromodomain in complex with cpd 30 (1-(3-(3-(1-methyl-1h-pyrazol-4-yl)isoquinolin-8-yl)-1-(tetrahydro-2h-pyran-4-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one)
44 124 6c3lA Crystal structure of bcl6 btb domain with compound 15f